Our research focuses on drug discovery and metabolomics with an aim toward development of therapeutic agents as drug leads applied in both communicable and non-communicable diseases. In addition to therapeutics, the group puts a lot of effort in identifying novel drug targets and to decipher drug metabolism processes with a view to influence the synthesis of even more robust chemical scaffolds.
